Shafaq News/ On Saturday, the Chairman of the Parliamentary Health and Environment Committee, Majid Shingali, voiced concerns regarding the financial management of Kimadia, Iraq's state-run pharmaceutical supplier, citing delays caused by the Ministry of Finance's handling of the company's contracts.

The General Company for the Import and Marketing of Medicines and Medical Supplies, known as Kimadia, is a public Iraqi company established in 1964. It is owned by the Ministry of Health and headquartered in Baghdad.

Shingali told Shafaq News Agency that Kimadia's budget, which falls under the ruling expenditures in the national budget, is valued at 1.66 trillion dinars. "Kimadia's contracts differ from others; they start with the contract, and then the transfer of funds before the manufacturing and shipping begin," he explained.